Searched for
NEGMA
- Investors unwilling to forgive Wockhardt, promoter for failingsForget its financial and legal woes, Habil Khorakiwala wants the world to notice that Wockhardt is on the road to recovery.03 Mar, 2011, 06.40 AM IST
- Wockhardt clocks Rs 565-cr loss in Q4Wockhardt has clocked a net loss of Rs 565.2 crore during Q4 FY10 compared to a net loss of Rs 10.2 crore during the corresponding period o...21 May, 2010, 01.44 AM IST
- Wockhardt may take forex issue to courtWockhardt is talking tough with banks that have unilaterally terminated their forex contracts with the company ahead of schedule.30 Jul, 2009, 12.32 AM IST
- Wockhardt may take forex issue to courtWockhardt is talking tough with banks that have unilaterally terminated their forex contracts with the company ahead of schedule.30 Jun, 2009, 01.25 AM IST
- Vetoquinol acquires Wockhardt's veterinary businessFrench veterinary company Vetoquinol has acquired the veterinary business of pharma company Wockhardt, pipping bigger rivals such as Pfizer...28 Jun, 2009, 02.39 PM IST
- Wockhardt's German arm sold for Rs 120 crWockhardt has sold its German subsidiary Esparma to another German company, Lindopharm GmbH, a move that is in line with its plan to divest...18 Jun, 2009, 12.01 AM IST
- Khorakiwala quits as MD amid Wockhardt debt pileMumbai-based pharma major Wockhardt on Tuesday announced a major organisational change and admitted that it was facing problems in servicin...01 Apr, 2009, 03.07 AM IST
- Wockhardt promoters pledge 40% for Rs 350 crThe Khorakiwala family, the promoters of pharmaceutical and biotechnology firm Wockhardt, pledged a 40% stake with financial institutions s...11 Feb, 2009, 12.30 AM IST
- Wockhardt may sell 2 foreign armsDrug major Wockhardt is looking for potential buyers for its French subsidiary Negma Laboratories to repay its debt to investors.19 Dec, 2008, 12.34 AM IST
- Pharma cos pop European pillDestination Europe seems to be the mantra that Indian pharma companies are following, as the sector ranked second highest in the maximum nu...02 Oct, 2008, 03.04 AM IST
- Wockhardt Q1 FY 08 sales up 50 per cent at Rs 786 crorePharmaceutical and bio-tech major Wockhardt Ltd on Monday posted its consolidated sales for the first quarter ended March 31, 2008 at Rs 78...28 Apr, 2008, 04.17 PM IST
- Wockhardt acquires US-based Morton GrovePharmaceutical major Wockhardt Ltd has acquired Morton Grove Pharmaceuticals, a liquid generic and specialty dermatology company in the US ...24 Oct, 2007, 11.46 AM IST
- Wockhardt buys Morton Grove of US; Q3 net profit down 35%Wockhardt Ltd has acquired Morton Grove Pharmaceuticals, a leading liquid generic and speciality dermatology company in the US having sales...24 Oct, 2007, 10.10 AM IST
- Wockhardt eyes $1 billion sales next fiscalWockhardt Hospitals, which has already filed the draft red herring prospectus with SEBI, expects to float an initial public offer (IPO) by ...15 Sep, 2007, 01.37 AM IST
- After strong Q1, Ranbaxy reclaims numero uno slotRanbaxy has reclaimed the top slot as the largest pharma company in India from Dr Reddy’s Laboratories.27 Jul, 2007, 02.40 AM IST
- Wockhardt gets a leg-up in EuropeWockhardt’s latest acquisition expands its footprint in Europe. Wockhardt will pay $265 million (Rs 1,090 crore) in cash to acquire Negma L...04 May, 2007, 12.26 AM IST
- Wockhardt buys French co for Rs 1,090 crWockhardt has acquired Negma Laboratories in cash - a deal that would give it access to the European mkt.03 May, 2007, 01.00 PM IST
Load More- Investors unwilling to forgive Wockhardt, promoter for failings
